R&D
더 나은 미래를 위해 SCM생명과학은 최선을 다할 것입니다.
성과
  • Phase 1/2 trials of human bone marrow–derivedclonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis
    Hyun-Min Seo, MD, PhD, Bark-Lynn Lew, MD, PhD, Yang Won Lee, MD, PhD, Sang Wook Son, MD, PhD, Chang Ook Park, MD, PhD, Young Lip Park, MD, PhD, et al
    J Allergy Clin Immunol 2024;154:965-73.
1